Hong Kong Pharma Digital Technology (HKPD) Stock Price, News & Analysis

Company Overview

Hong Kong Pharma Digital Technology (NASDAQ: HKPD) is a healthcare technology company specializing in the digital transformation of pharmaceutical distribution, retail and clinical services. The firm leverages advanced data analytics, cloud computing and e-commerce solutions to streamline the procurement, storage and delivery of medicines. Its integrated platform connects pharmaceutical manufacturers, wholesalers, healthcare providers and end-consumers, enhancing supply-chain transparency and accelerating access to essential therapies.

The company’s product suite includes an online pharmacy portal, a B2B ordering system for institutional clients, and telemedicine services. Through its online pharmacy, patients in Hong Kong and select regions of Mainland China can securely purchase prescription and over-the-counter medications, with real-time order tracking and home delivery options. Its B2B platform enables hospitals, clinics and retail pharmacies to manage inventory, forecast demand and place bulk orders. Additionally, Hong Kong Pharma Digital Technology offers telehealth consultations, connecting patients to licensed medical professionals via video conferencing and in-app messaging.

Founded in 2017, the company initially focused on regulatory compliance and digital record-keeping for Hong Kong’s pharmacy sector. It subsequently expanded into Mainland China and Southeast Asia, forming partnerships with regional distributors, logistics providers and healthcare institutions. Over time, the business has grown to include AI-driven prescription verification and cold-chain monitoring solutions, addressing the evolving needs of an increasingly digital healthcare ecosystem.

Hong Kong Pharma Digital Technology is led by Chief Executive Officer David Chen, a pharmaceutical industry veteran with over two decades of experience in supply-chain optimization and healthcare IT. The senior management team includes Chief Technology Officer Lily Wong, who oversees platform development and cybersecurity, and Chief Operating Officer Marcus Lee, responsible for strategic partnerships and market expansion. Under this leadership, the company continues to drive innovation in digital pharmacy services and build a scalable infrastructure to support future growth.

Key Stats

• Today's Range: $1.37 to $1.41
• 50-Day Range: $0.89 to $2.15
• 52-Week Range: $0.81 to $3.79
• Volume: 19,140 shs
• Average Volume: 1.09 million shs
• Market Capitalization: $15.18 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

HKPD Stock Analysis - Frequently Asked Questions

How have HKPD shares performed this year?

Hong Kong Pharma Digital Technology's stock was trading at $2.69 on January 1st, 2025. Since then, HKPD stock has decreased by 48.3% and is now trading at $1.39.

When did Hong Kong Pharma Digital Technology IPO?

Hong Kong Pharma Digital Technology (HKPD) raised $6 million in an initial public offering (IPO) on Wednesday, January 15th 2025. The company issued 1,403,685 shares at a price of $4.00 per share.

When did Hong Kong Pharma Digital Technology's lock-up period expire?

Hong Kong Pharma Digital Technology's lock-up period expired on Monday, July 14th. Hong Kong Pharma Digital Technology had issued 1,403,685 shares in its public offering on January 15th. The total size of the offering was $5,614,740 based on an initial share price of $4.00. Since the expiration of Hong Kong Pharma Digital Technology's lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company have been lifted.

How do I buy shares of Hong Kong Pharma Digital Technology?

Shares of HKPD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 7/18/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Retail/Wholesale
• Industry: Wholesale – Drugs & Drug Proprietaries
• Sub-Industry: Wholesale
• Current Symbol: NASDAQ:HKPD
• CIK: 2007702
• Web: N/A
• Phone: (852) 26189289
• Fax: N/A
• Employees: 19
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 11,000,000
• Free Float: N/A
• Market Cap: $15.07 million
• Optionable: N/A
• Beta: N/A